Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Vaughn

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Vaccine|August 31, 2007
Role of U.S. military research programs in the development of U.S.-licensed vaccines for naturally occurring infectious diseasesLynn W Kitchen, David W Vaughn
BMJ (Clinical Research Ed.)|June 29, 2002
Dengue: an escalating problemRobert V Gibbons, David W Vaughn
Advances in Virus Research|January 13, 2004
Dengue epidemiology: virus epidemiology, ecology, and emergenceStephen J Thomas, Daniel Strickman, David W Vaughn
Expert Review of Vaccines|March 3, 2012
Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsionNathalie Garçon, David W Vaughn, Arnaud M Didierlaurent
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 8, 2006
Role of US military research programs in the development of US Food and Drug Administration--approved antimalarial drugsLynn W Kitchen, David W Vaughn, Donald R Skillman
The Pediatric Infectious Disease Journal|November 10, 2015
Assessment of Prime-boost Vaccination Using an AS03B-adjuvanted Influenza A (H5N1) Vaccine: A Randomized Trial in Children of Three to Less Than Eighteen Years of AgePatricia Izurieta, Mercy Jeane Uy-Aragon, Mamadou Dramé, et al.
The American Journal of Tropical Medicine and Hygiene|July 24, 2003
Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genesRobert Putnak, James Fuller, Lorna VanderZanden, et al.
The Journal of Infectious Diseases|May 28, 2014
Responses to A(H1N1)pdm09 influenza vaccines in participants previously vaccinated with seasonal influenza vaccine: a randomized, observer-blind, controlled studySumita Roy-Ghanta, Robbert Van der Most, Ping Li, et al.
Vaccine|August 5, 2014
Immunogenicity and safety of AS03A-adjuvanted H5N1 influenza vaccine prepared from bulk antigen after stockpiling for 4 yearsOlivier Godeaux, Patricia Izurieta, Miguel Madariaga, et al.
Journal of Virology|September 16, 2006
Characterization of antibody responses to combinations of a dengue virus type 2 DNA vaccine and two dengue virus type 2 protein vaccines in rhesus macaquesMonika Simmons, Kevin R Porter, Curtis G Hayes, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Vaccine|August 31, 2007
Role of U.S. military research programs in the development of U.S.-licensed vaccines for naturally occurring infectious diseasesLynn W Kitchen, David W Vaughn
BMJ (Clinical Research Ed.)|June 29, 2002
Dengue: an escalating problemRobert V Gibbons, David W Vaughn
Advances in Virus Research|January 13, 2004
Dengue epidemiology: virus epidemiology, ecology, and emergenceStephen J Thomas, Daniel Strickman, David W Vaughn
Expert Review of Vaccines|March 3, 2012
Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsionNathalie Garçon, David W Vaughn, Arnaud M Didierlaurent
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 8, 2006
Role of US military research programs in the development of US Food and Drug Administration--approved antimalarial drugsLynn W Kitchen, David W Vaughn, Donald R Skillman
The Pediatric Infectious Disease Journal|November 10, 2015
Assessment of Prime-boost Vaccination Using an AS03B-adjuvanted Influenza A (H5N1) Vaccine: A Randomized Trial in Children of Three to Less Than Eighteen Years of AgePatricia Izurieta, Mercy Jeane Uy-Aragon, Mamadou Dramé, et al.
The American Journal of Tropical Medicine and Hygiene|July 24, 2003
Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genesRobert Putnak, James Fuller, Lorna VanderZanden, et al.
The Journal of Infectious Diseases|May 28, 2014
Responses to A(H1N1)pdm09 influenza vaccines in participants previously vaccinated with seasonal influenza vaccine: a randomized, observer-blind, controlled studySumita Roy-Ghanta, Robbert Van der Most, Ping Li, et al.
Vaccine|August 5, 2014
Immunogenicity and safety of AS03A-adjuvanted H5N1 influenza vaccine prepared from bulk antigen after stockpiling for 4 yearsOlivier Godeaux, Patricia Izurieta, Miguel Madariaga, et al.
Journal of Virology|September 16, 2006
Characterization of antibody responses to combinations of a dengue virus type 2 DNA vaccine and two dengue virus type 2 protein vaccines in rhesus macaquesMonika Simmons, Kevin R Porter, Curtis G Hayes, et al.
Pageof 10